<SEC-DOCUMENT>0001193125-20-115804.txt : 20200521
<SEC-HEADER>0001193125-20-115804.hdr.sgml : 20200521
<ACCEPTANCE-DATETIME>20200423061732
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-20-115804
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oric Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001796280
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				471787157
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		240 E. GRAND AVE.
		STREET 2:		2ND FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 388-5600

	MAIL ADDRESS:	
		STREET 1:		240 E. GRAND AVE.
		STREET 2:		2ND FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g843476wilsonsosini.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wilson Sonsini Goodrich&nbsp;&amp; Rosati</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Professional Corporation</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">650 Page Mill Road</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palo Alto, California 94304-1050</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><SMALL>O</SMALL>: 650.493.9300</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><SMALL>F</SMALL>: 650.493.6811</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;23, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>Via EDGAR and Overnight Delivery </U></I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S.
Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Life Sciences </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey Gabor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ibolya Ignat </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Celeste Murphy </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kevin Vaughn </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ORIC Pharmaceuticals, Inc. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Amendment No.&nbsp;1 to Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Filed April&nbsp;20, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;333-236792</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sir/Madam: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On behalf of our client, ORIC
Pharmaceuticals, Inc. (&#147;<B>ORIC</B>&#148; or the &#147;<B>Company</B>&#148;), we submit this letter in response to comments from the staff (the &#147;<B>Staff</B>&#148;) of the Securities and Exchange Commission (the
&#147;<B>Commission</B>&#148;) contained in its letter dated April&nbsp;22, 2020, relating to the above referenced Amendment No.&nbsp;1 to Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (the &#147;<B>Registration</B>
<B>Statement</B>&#148;). We are concurrently filing via EDGAR a revised Registration Statement (the &#147;<B>Revised Registration Statement</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this letter, we have recited the comments from the Staff in italicized, bold type and have followed each comment with the Company&#146;s
response. Except for page references appearing in the headings and Staff comments below (which are references to the Registration Statement), all page references herein correspond to the Revised Registration Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">AUSTIN&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BEIJING&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BOSTON&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;BRUSSELS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HONG KONG&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LONDON&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LOS ANGELES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NEW
YORK&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PALO ALTO </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">SAN DIEGO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SAN
FRANCISCO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SEATTLE&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SHANGHAI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WASHINGTON, DC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WILMINGTON, DE </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ORIC Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 23, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>Amendment No.&nbsp;1 to Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT>
filed April&nbsp;20, 2020 </U></I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>Risk Factors </U></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>Our amended and restated bylaws that will become effective upon the closing of this offering provide..., page 79 </U></I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>1.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>We note that your forum selection provision identifies a state court located within the State of Delaware
(or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) as the exclusive forum for certain litigation, including any &#147;derivative action.&#148; Please
disclose whether this provision applies to actions arising under the Exchange Act. If this provision does not apply to actions arising under the Exchange Act, please also ensure that the exclusive forum provision in the governing documents states
this clearly, or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Exchange Act. We also note that your forum selection provision includes an exclusive federal forum provision
for Securities Act claims. Please state that there is uncertainty as to whether a court would enforce such provision. In that regard, we note that Section&nbsp;22 of the Securities Act creates concurrent jurisdiction for federal and state courts
over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. </I></B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In response to the Staff&#146;s comment, the Company has updated the disclosure on pages&nbsp;79 and 80 of the Revised Registration Statement.
Additionally, the Company will include disclosure in future Annual Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> to describe the limitations in applicability of the Company&#146;s forum selection provision, consistent with the
disclosure on pages&nbsp;79 and 80. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>Report of Independent Registered Public Accounting Firm, page <FONT STYLE="white-space:nowrap">F-2</FONT>
</U></I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>2.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Please have your auditors remove the restrictive language from their report and consent and sign them in
the filing for which you request effectiveness. </I></B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In response to the Staff&#146;s comment, the Company&#146;s
auditors have removed the restrictive language from their report and consent and signed these for inclusion in the filing for which the Company requests effectiveness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">***** </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ORIC Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 23, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please direct any questions regarding the Company&#146;s responses or the revised draft of
the Registration Statement to me at <FONT STYLE="white-space:nowrap">(650)&nbsp;849-3223</FONT> or tjeffries@wsgr.com. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">WILSON SONSINI GOODRICH&nbsp;&amp; ROSATI<BR>Professional Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tony Jeffries</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tony Jeffries</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jacob Chacko, ORIC Pharmaceuticals, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Dominic Piscitelli, ORIC Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Kenneth Clark, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Jennifer Knapp, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Melissa Rick, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Charles Kim, Cooley LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g843476wilsonsosini.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g843476wilsonsosini.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M^#I_]D;0/@U^UGX2^(7A_3[;38?BIIES_;=O!%LCFU&UD0/=GG_6317$8?
M)M]YR\CD_KQ_P1^^.%]^T5_P3,^#7BK4YI+K4[CP^FGWL\AW-//9R/9R2$^K
M/;LWKSU/6L<PI4Y4X8FDK*6Z\SIR7$5X5ZF7XB7,X6:?5I]_P/S]_P"#JO\
M:"\??!#XB_ F/P5XY\8^#XM3TW7WO$T36;G3UNVCETP(9!$ZARH=\%LXWMCJ
M:U/^#<;_ (+"ZA\697^ GQ9\17^K>*$\V\\(:[JUYY]QJL7WY=/EED.^2>/+
M21$EBT0=<KY*A_/?^#OKGXF?L]_]@OQ'_P"CM*K\U/BG^SEXZ_9(\/?!WXG6
M]U=VNG>/=+M?%GA7Q!9*T+65[#(&> -SMN+:9%8$'#(T;C&61/0PN'I5L%&G
M+1N]GYH\;,L?B<+FTZ].[A%1YEY-=C^H[_@H)K]]X5_85^,6IZ7?7FFZEI_@
MS5KBUN[29H9[:5;25E='4AE92 000017\X7[*G[;/QHUM]>^V_%_XI7GE):[
M//\ %5])LSYV<9EXS@?D*_7OX)_\%-=+_P""EG_!%?XR:I=O:V?Q&\)^!-3T
MWQ?IL;CBX^P3;+V-, K;W(1W08PC++%N<Q%C^&W[('^L\0_[EI_[6K/+:'+"
MI"HM4T;9]C/:5\/4HR]V2;T/Z//^"VO[+[?M8?\ !-#XFZ'9VIO-<T'3CXGT
M>)$WRRW=AFX$48_ORQI)".G,W/&:_F=T?]H[7[#]EO6/A/#<>9X3USQ19>+V
M3=PEU!:3VI(&.1(DL))SQ]F3@YR/[#IH4N(6CD59(Y 596&58'J"*_FI_:%_
MX-__ -H*T_:]\7>&?!WP[U:;P#<^*9;;1?$,<]LUM;Z9//NAG;=(K$PPR+O&
MT?/$X QBL\GQ-.,94ZK5EJKFW%.!Q%2<*V%3;:<7;L^_D?HQ_P $4?\ @G5I
MOB;_ ((?^)/#>O1B"^_:(M-3O[J=H$>6RAFB-I8,A(Y\N.&.Y0-]V29L5^'/
M@3XT^+OV<_!OQ8^'ZB2P;Q]IT7ACQ%"MQ)'Y#6FHPW# !2 YW030'<"/+N9A
M_$:_KM^'7@'2OA1\/M!\+:#:BQT/PUIUOI6G6X8L(+>"-8HDR>3M15&3Z5^
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MW<+3]A+GC67L^U_T/C\RK?7:;HSPLE6Z.VSOO?M_7F?JU_P;<?M#^*OV@_\
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M(YL-"E;9L,/@U#'5,1?XDE;T/QX_X.7O^"4"^$-6O/VE/ &G1QZ5J#J/'UA
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/GB#*5C7!N7+RWZ7WL?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
